Differential time- and NADPH-dependent inhibition of CYP2C19 by enantiomers of fluoxetine
Highly selective inhibition of human CYP3Aa in vitro by azamulin and evidence that inhibition is irreversible
Predictive In Vitro-In Vivo Extrapolation for Time Dependent Inhibition of CYP1A2, CYP2C8, CYP2C9, CYP2C19, and CYP2D6 Using Pooled Human Hepatocytes, Human Liver Microsomes, and a Simple Mechanistic Static Model
Visit Discovery at Booth #919 during SITC 2024 November 6-10, 2024 | George R. Brown Convention Center, Houston, Texas View Discovery's Poster Presentation at SITC 2024 Presented by Dr. Dirk […]
Join Discovery Life Sciences at ASHG 2024 November 5-9, 2024 | Colorado Convention Center, Denver, Colorado Schedule a Meeting at ASHG
Join Discovery at World ADC, November 4-7 in San Diego. Be sure to stop by Booth 502 and meet with your experts: Emer Clarke, PhD, VP, Cell Biology Christina Moskowitz, […]
Copyright © 2024 Discovery Life Sciences. All rights reserved.
Designed & Developed by Altitude Marketing
